Cargando…
Small molecules that inhibit TNF signalling by stabilising an asymmetric form of the trimer
Tumour necrosis factor (TNF) is a cytokine belonging to a family of trimeric proteins; it has been shown to be a key mediator in autoimmune diseases such as rheumatoid arthritis and Crohn’s disease. While TNF is the target of several successful biologic drugs, attempts to design small molecule thera...
Autores principales: | O’Connell, James, Porter, John, Kroeplien, Boris, Norman, Tim, Rapecki, Stephen, Davis, Rachel, McMillan, David, Arakaki, Tracy, Burgin, Alex, Fox III, David, Ceska, Tom, Lecomte, Fabien, Maloney, Alison, Vugler, Alex, Carrington, Bruce, Cossins, Benjamin P, Bourne, Tim, Lawson, Alastair |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6923382/ https://www.ncbi.nlm.nih.gov/pubmed/31857588 http://dx.doi.org/10.1038/s41467-019-13616-1 |
Ejemplares similares
-
Structural insights into the disruption of TNF-TNFR1 signalling by small molecules stabilising a distorted TNF
por: McMillan, David, et al.
Publicado: (2021) -
A conformation-selective monoclonal antibody against a small molecule-stabilised signalling-deficient form of TNF
por: Lightwood, Daniel J., et al.
Publicado: (2021) -
Discovery and characterization of olokizumab: A humanized antibody targeting interleukin-6 and neutralizing gp130-signaling
por: Shaw, Stevan, et al.
Publicado: (2014) -
Trimeric Structure of Langerin
por: Feinberg, Hadar, et al.
Publicado: (2010) -
Talar-tarsal Stabilisation: Goals and Initial Outcomes
por: Stevens, Peter, et al.
Publicado: (2021)